HMGB1 and Sepsis: Emerging evidence suggests that exosomal biomarkers – proteins like HMGB1, miRNAs such as miR-122, and even lncRNAs/circRNAs – could enhance our ability to diagnose sepsis early, monitor organ damage, and stratify patients for tailored therapies.